Trademark: 97469841
Word
RAZFI
Status
Pending
Status Code
730
Status Date
Monday, December 18, 2023
Serial Number
97469841
Mark Type
4000
Filing Date
Wednesday, June 22, 2022
Published for Opposition
Tuesday, May 9, 2023

Trademark Owner History
Eli Lilly and Company - Owner At Publication

Classifications
5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Trademark Events
Dec 20, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 18, 2023
Sou Extension 1 Granted
Dec 18, 2023
Sou Extension 1 Filed
Dec 18, 2023
Sou Teas Extension Received
Jul 4, 2023
Noa E-Mailed - Sou Required From Applicant
May 9, 2023
Official Gazette Publication Confirmation E-Mailed
May 9, 2023
Published For Opposition
Apr 19, 2023
Notification Of Notice Of Publication E-Mailed
Apr 5, 2023
Approved For Pub - Principal Register
Apr 4, 2023
Assigned To Examiner
Jul 9, 2022
New Application Office Supplied Data Entered
Jun 25, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24